Centre for Liver Transplant Surgery, Bangalore

End-stage liver disease demands more than medication — it demands a surgeon who has performed this operation hundreds of times, a team built around the single goal of keeping both donor and recipient safe, and a programme that stays with the patient long after they leave the ICU.

Dr. Srinivas Bojanapu  —  MS · DrNB · PDF  —  Hepatologist, Liver Transplant & HPB Surgeon, Bangalore

ZCCK Listed
TRANSTAN Listed
95%+ LDLT Success
Liver Transplant Surgery Bangalore — Dr. Srinivas Bojanapu performing LDLT procedure

When Is Liver Transplantation the Only Option?

The liver is a resilient organ — it can compensate for significant damage for years before giving way. But when compensation fails and the liver can no longer perform its core functions — filtering toxins, producing clotting factors, metabolising drugs, synthesising proteins, and maintaining fluid balance — liver transplantation becomes the only intervention that can restore normal physiology and save the patient's life.

As a liver transplant surgeon in Bangalore, Dr. Srinivas Bojanapu evaluates every patient for transplant candidacy based on the severity of liver dysfunction (quantified by MELD score), the underlying cause of disease, the presence of complications such as hepatic encephalopathy, refractory ascites or hepatorenal syndrome, and the patient's overall physiological reserve. Transplantation is not recommended lightly — the decision is made only when the benefits of surgery clearly outweigh the risks of a major operation and lifelong immunosuppression.

  • Decompensated Cirrhosis When cirrhosis progresses beyond compensation to jaundice, ascites, variceal bleeding, or hepatic encephalopathy that cannot be controlled with medical or endoscopic therapy.
  • Acute Liver Failure Sudden, life-threatening liver collapse from viral hepatitis, drug toxicity (paracetamol overdose, herbal supplements), or Wilson's disease, requiring emergency listing through the ZCCK or TRANSTAN deceased donor registry.
  • HCC within Milan Criteria A single tumour ≤5 cm, or up to three tumours each ≤3 cm, confined to the liver with no vascular invasion. Transplant offers both oncological cure and removal of the cirrhotic background liver that would generate future tumours.
  • Alcohol-Related Liver Disease Selected patients with severe alcoholic hepatitis unresponsive to steroids, or end-stage alcoholic cirrhosis, following rigorous psychosocial evaluation and documented sobriety commitment.
  • Metabolic Liver Diseases Wilson's disease, end-stage haemochromatosis, MASLD-related F4 cirrhosis with complications, and primary biliary cholangitis or primary sclerosing cholangitis failing all medical therapies.
  • Chronic Hepatitis B & C Cirrhosis Despite highly effective antivirals (TAF for HBV, DAAs for HCV), patients who present late with established decompensated cirrhosis will not recover adequate synthetic function on medications alone and require transplant evaluation.
Clinical Reference — MELD Score

MELD (Model for End-Stage Liver Disease) is the universal scoring system used to prioritise liver transplant candidates. Calculated from serum creatinine, bilirubin, INR, and sodium, a MELD score above 15 generally indicates that transplant improves survival over medical management. Scores above 25 carry a 3-month mortality exceeding 50% without transplant. All patients with MELD ≥15 should be referred to a liver transplant surgeon in Bangalore for evaluation without delay.

The Dual-Track Programme — Two Pathways to a New Liver

Our transplant programme in Bangalore offers both pathways simultaneously. This is clinically important: many patients are evaluated for LDLT and DDLT in parallel, so that if the preferred living donor is found to be unsuitable at the last stage of workup, the deceased donor listing is already active. LDLT provides speed, organ quality, and surgical control; DDLT provides access for patients without a compatible living donor.

Living Donor (LDLT)

The gold standard for elective transplantation. A healthy, ABO-compatible relative donates the right lobe of their liver — approximately 60% of the total volume. Surgery is planned, timing is controlled, and organ quality is prime. The donor's liver regenerates to near-normal volume within 6–8 weeks.

Explore LDLT Programme
Deceased Donor (DDLT)

For patients without a suitable living donor. The whole liver is retrieved from a brain-dead donor through the ZCCK (Karnataka) or TRANSTAN (Tamil Nadu) government registry, with allocation governed strictly by MELD score and blood group. Surgery is performed on an emergency basis, often at night.

Explore DDLT Programme
Outcomes & Success Data

Transparent 1-year and 5-year survival statistics for our programme, benchmarked against international registries including UNOS and ELTR. Published outcomes drive accountability and help patients make fully informed decisions.

View Our Outcomes

LDLT vs DDLT — A Detailed Comparison

Choosing between a living donor and a deceased donor transplant is one of the most consequential decisions a patient and family will make. The comparison below covers every factor that influences the choice — from organ quality and surgical timing to cost structure and donor risk. This table is reviewed in detail at every transplant consultation at our Bangalore centre.

Scroll right to view full table on mobile.

Feature Living Donor (LDLT) Deceased Donor (DDLT)
Donor SourceHealthy blood relative or spouseBrain-dead patient via ZCCK / TRANSTAN
Waiting Time2–3 weeks (planned)Months to years (uncertain)
Organ QualityOptimal — healthy donor, full pre-operative evaluationVariable — depends on donor age, ICU duration, and cause of death
Surgery TimingElective, daytime, full planned teamEmergency — often midnight or weekend
Organ TransplantedRight lobe (~60% of donor liver volume)Whole liver
Allocation BasisFamily and clinical decisionGovernment MELD score + blood group priority
1-Year Patient Survival~95% (elective cases)~90% (very good)
Cost StructureTwo operations: donor surgery + recipient surgeryHigher organ retrieval, transport, and extended ICU costs
Donor RiskSmall but real — 0.1–0.5% major complication rate in high-volume centresNo donor risk (deceased)
Cold Ischaemia TimeVery short — liver transplanted same day, same centreLonger — retrieval, transport, and back-table preparation add hours
Best ForPatients with a healthy, willing, compatible relativePatients without a suitable living donor candidate
Surgeon's Note Wherever a suitable living donor exists, LDLT remains the preferred option — not only because of the shorter waiting time, but because the elective surgical environment reduces anaesthetic risk for the recipient, and the donor liver is healthier with a shorter cold ischaemia time. However, this preference should never create pressure on a family member. Donor autonomy is absolute. An independent surgical team evaluates every potential donor separately to eliminate any conflict of interest.

The Pre-Transplant Evaluation — What to Expect

Before any patient is listed for transplant — whether LDLT or DDLT — they undergo a comprehensive multi-disciplinary workup that typically takes place over five days at our Bangalore centre. This evaluation serves two purposes: to confirm that transplant is the correct treatment, and to identify and optimise any conditions that could increase peri-operative risk. The same evaluation applies independently to the proposed living donor, conducted by a separate surgical team to ensure no conflict of interest influences the assessment.

Day 1 — Baseline Bloods & Cross-Sectional Imaging

Complete liver function panel, viral serology (HBV surface antigen, HCV antibody, HIV, CMV, EBV), full blood count, coagulation screen, renal function, thyroid, and tumour markers (AFP, CA 19-9). Triphasic CT abdomen and pelvis to assess portal vein anatomy, hepatic arterial supply, liver volume, and any space-occupying lesions. Chest X-ray and 12-lead ECG.

Day 2 — Cardiac & Pulmonary Clearance

2D Echocardiography to measure ejection fraction, pulmonary arterial pressure, and valvular function. Dobutamine stress echocardiography if ischaemic heart disease is suspected. Pulmonary function tests (spirometry). Arterial blood gas to screen for hepatopulmonary syndrome. Cardiology sign-off is mandatory before listing.

Day 3 — GI Endoscopy & Specialist Reviews

Upper GI endoscopy to screen for oesophageal and gastric varices, with prophylactic endoscopic variceal ligation (EVL) applied if high-risk varices are found. Nephrology review if creatinine is elevated or hepatorenal syndrome is suspected. Dental clearance to eliminate oral sepsis. Chest CT if any pulmonary nodule or lesion is seen on chest X-ray.

Day 4 — Psychosocial Assessment & Financial Counselling

Psychiatry evaluation — particularly important for patients with alcohol-related liver disease, where a minimum 6-month period of documented sobriety is required. Social worker assessment of family support structure, post-discharge care capacity, and compliance likelihood. Transplant coordinator review of insurance pre-authorisation, government scheme eligibility, and total cost estimation.

Day 5 — Multidisciplinary Transplant Board Decision

Hepatologist, liver transplant surgeon, transplant anaesthetist, intensivist, cardiologist, and transplant coordinator review all findings collectively in a formal MDT meeting. A final listing decision is documented, the MELD score is recorded for registry submission (ZCCK or TRANSTAN), and an estimated surgical date is confirmed for LDLT cases where a donor has cleared evaluation.

⚠ Do Not Delay Evaluation

Patients with a MELD score above 20 should seek transplant evaluation without delay. Above MELD 25, 90-day mortality without transplant exceeds 30%. Early evaluation does not commit a patient to surgery — it preserves the option if and when it becomes necessary, and critically, allows time to identify and prepare a living donor.

Safety Protocols & Infection Control

Liver transplant recipients are placed on high-dose immunosuppression in the early post-operative period, making them profoundly susceptible to bacterial, fungal, and viral infections during the critical first 90 days. Our transplant programme in Bangalore employs a multi-layered infection prevention strategy, maintained continuously by the nursing, pharmacy, and intensivist teams around the clock.

HEPA Filtration ICU Positive-pressure rooms with HEPA-filtered air that eliminates 99.97% of airborne particles, bacteria, and fungal spores including Aspergillus fumigatus.
Tumour Board Review Every HCC patient referred for transplant is reviewed by an oncology tumour board before listing, ensuring strict adherence to Milan or UCSF criteria.
24/7 Transplant Intensivists Dedicated ICU physicians trained in transplant haemodynamics monitor tacrolimus levels, bile output, and graft function throughout the post-operative window.
Drug Level Monitoring Tacrolimus trough levels measured daily for the first two weeks to maintain the narrow therapeutic window that prevents both rejection and nephrotoxicity.
Prophylactic Antimicrobials Standardised protocol using fluconazole (antifungal), valganciclovir (CMV prophylaxis), and trimethoprim-sulfamethoxazole (PCP prevention) for the first 6–12 months.
Protocol Liver Biopsies Scheduled graft biopsies at 1 week and 1 month post-transplant to detect subclinical rejection and recurrent disease before clinical deterioration occurs.

Life After Liver Transplant — The Long-Term Picture

A successful liver transplant is not the end of treatment — it is the beginning of a new chapter that requires lifelong engagement with the transplant team. The first year is the most demanding: drug doses change weekly, the immune system is being recalibrated, and the graft is still being accepted. Beyond 12 months, the vast majority of patients lead near-normal lives, return to work, travel, and require only quarterly or biannual reviews. Understanding the trajectory allows patients and families to plan realistically.

  • Hospital Discharge Timeline Recipients typically spend 5–7 days in the transplant ICU, followed by 10–15 days in the hepatology ward. Total hospitalisation for uncomplicated LDLT is 15–22 days. Donors are discharged in 5–7 days.
  • Immunosuppression for Life Tacrolimus (FK506) remains the backbone of long-term immunosuppression, typically combined with mycophenolate mofetil in the first year. Doses are reduced progressively as tolerance develops but cannot be discontinued.
  • Follow-Up Schedule Weekly for the first month, fortnightly for months 2–3, monthly through the first year, then quarterly indefinitely. Blood tests at every visit monitor graft function, drug levels, and renal function.
  • Dietary Restrictions High-protein, low-sodium diet for the first 6 months. Raw or undercooked foods are prohibited while on high-dose immunosuppression. Grapefruit and pomelo are permanently contraindicated due to CYP3A4 inhibition which dangerously elevates tacrolimus levels.
  • Permanent Prohibitions Alcohol — zero tolerance, lifelong. Herbal and Ayurvedic supplements — many are hepatotoxic and can precipitate acute graft rejection by competing with immunosuppressant metabolism. NSAIDs — nephrotoxic in combination with tacrolimus and calcineurin inhibitors.
  • Return to Normal Activity Light walking from week 2 post-discharge. Driving from week 6–8. Desk work and light activity from month 2. Physical labour, contact sports, or heavy lifting only after 6 months and with explicit surgical clearance.
Long-Term Survival Data

Published data from high-volume liver transplant centres internationally show 5-year patient survival rates of 75–80% for LDLT and 70–75% for DDLT. Beyond the first year, the primary causes of late death are cardiovascular disease and de-novo malignancy — both driven by long-term immunosuppression — rather than graft failure. Annual cancer surveillance (colonoscopy, skin examination, PSA in men, mammography in women) is recommended from year 3 post-transplant onwards as part of the standard long-term follow-up protocol.

The Multidisciplinary Transplant Team

Liver transplantation is the most team-dependent operation in surgery. The outcome is determined not just by the surgical technique of the liver transplant surgeon but by the integrated performance of every specialist who touches the patient from the moment of listing to the decade of follow-up that follows. Our transplant team in Bangalore is constituted to cover every dimension of this journey.

Transplant Coordinators
Manage ZCCK and TRANSTAN listing, legal documentation, ethical committee consent, insurance pre-authorisation, and family communication throughout every stage of the transplant process.
Transplant Anaesthetists
Specialists in haemodynamic management during the most critical phase of the operation — the anhepatic phase — when no functioning liver exists in the body and coagulation, cardiac output, and renal perfusion must be maintained artificially.
Hepatopathologists
Perform intraoperative frozen-section biopsies of the donor graft to assess steatosis and viability, and post-transplant protocol biopsies at weeks 1 and 4 to detect acute cellular rejection before it causes clinical deterioration.
Transplant Nutritionists
Design nutritionally dense, infection-safe meal plans for the immunocompromised post-transplant period, with specific attention to reversing the sarcopenia and muscle wasting that is near-universal in patients with end-stage liver disease.
Transplant Psychiatrists
Evaluate medication compliance likelihood, screen for depression and anxiety (both extremely common in end-stage liver disease), and provide psychological support throughout what is an emotionally complex process for patients and families alike.
Physiotherapists
Begin prehabilitation before surgery to improve physical conditioning, and guide post-operative respiratory physiotherapy, early mobilisation, and the graduated exercise programme designed to restore functional independence after major abdominal surgery.

Common Questions — Liver Transplant in Bangalore

What is the success rate of liver transplant surgery in Bangalore?
At our centre, the success rate for elective Living Donor Liver Transplant (LDLT) exceeds 95%, and for Deceased Donor Liver Transplant (DDLT) it is approximately 90%, measured as 1-year patient and graft survival. These figures are consistent with outcomes published by UNOS and ELTR, the major international transplant registries.
What is the difference between LDLT and DDLT?
LDLT (Living Donor Liver Transplant) uses the right lobe from a healthy, ABO-compatible relative. It is performed electively with a short waiting time of 2–3 weeks. DDLT (Deceased Donor Liver Transplant) uses a whole liver from a brain-dead donor allocated through the ZCCK or TRANSTAN government registry by MELD score and blood group. Waiting time is unpredictable, ranging from months to years.
How long is the waiting list for deceased donor transplant in Bangalore?
Waiting time depends on blood group, MELD score, and organ availability through ZCCK (Karnataka) or TRANSTAN (Tamil Nadu). Blood group O-Positive may require 6–12 months. Patients with higher MELD scores receive priority. Deceased donor allocation in India is strictly regulated by the Government Transplant Authority — unofficial access to organs is both illegal and medically dangerous.
Can a diabetic person donate part of their liver?
Generally no. Donors requiring antidiabetic medication are excluded from donation. However, pre-diabetes controlled entirely by diet and lifestyle modification with no medication, combined with a normal liver biopsy and otherwise meeting all donor evaluation criteria, may be considered on a case-by-case basis by the independent donor assessment team.
Does the liver grow back after living donor transplant?
Yes. The liver is the only solid organ in the human body with the capacity for complete regeneration. The donor's residual left lobe (approximately 35–40% of total liver mass) regenerates to near-normal functional volume within 6–8 weeks, driven by Hepatocyte Growth Factor (HGF) signalling and hepatocyte proliferation. Donors are typically back to full activity within 4–6 weeks.
What is the age limit for liver transplant?
Recipients up to 70 years of age are typically considered, subject to cardiovascular fitness, renal function, frailty score, and absence of significant comorbidities that would make them unable to tolerate major surgery. There is no rigid upper age limit — the decision is individualised based on physiological rather than chronological age, determined through comprehensive pre-transplant evaluation.
Is blood group matching mandatory?
ABO blood group compatibility is strongly preferred as it reduces the risk of antibody-mediated rejection. However, when no compatible donor is available, ABO-Incompatible (ABOi) liver transplant is possible using a desensitisation protocol combining plasmapheresis (to remove anti-blood group antibodies), rituximab (B-cell depletion), and intravenous immunoglobulin, administered in the 2–3 weeks before surgery.
Will I need medicines for life after transplant?
Yes. All recipients require lifelong immunosuppressive therapy — most commonly tacrolimus — to prevent the immune system from rejecting the transplanted liver. Doses are progressively reduced over months to years but cannot be permanently discontinued. Donors, by contrast, require no long-term medication and are typically medically discharged within 4–6 weeks of surgery with a return to full normal health.

Ready to Discuss Transplant Options?

A detailed consultation with Dr. Srinivas Bojanapu will cover your current liver status, MELD score, living donor suitability assessment, and a realistic timeline to transplantation.

Book a Transplant Consultation